Shares of Silence Therapeutics (LON:SLN) break above its 200-day moving average of $535.00

Silence Therapeutics plc (LON:SLN – Get Your Free Report ) share price broke above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 535 ($6.83) and traded as high as GBX 546 ($6.97). Shares of Silence Therapeutics last traded at GBX 535 ($6.83), with a volume of 913,528 shares traded.

Silence Therapeutics trades down 0.9%

The stock has a market cap of £480.35 million and a PE ratio of -11.01. The firm has a 50-day simple moving average of GBX 535 and a 200-day simple moving average of GBX 535. The company has a quick ratio of 4.36, a current ratio of 4.52, and a debt-to-equity ratio of 0.80.

Silence Therapeutics Company Profile

(Get a free report)

Silence Therapeutics plc, a biotechnology company, is focused on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular and other rare and metabolic indications. The company’s platform includes the mRNAi GalNAc Oligonucleotide Discovery platform designed to precisely target specific genes associated with liver disease.

Recommended articles

Receive news and reviews for Silence Therapeutics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Silence Therapeutics and related companies with MarketBeat.com ‘s FREE daily email newsletter.